A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The Centers for Medicare and Medicaid Services on Friday issued a 2026 Medicare Advantage and Part D final rule that makes changes to authorization decisions. One provision restricts a plan's ability ...

Experts discuss the cost of lipoprotein(a) (Lp[a]) tests and how these costs, along with the National Lipid Association’s (NLA) recommendation and supporting clinical evidence, may influence payer ...

Panelists discuss how integrating real-world evidence into coverage frameworks can enhance decision-making and align payer policies with actual patient outcomes. Panelists discuss how real-world ...